Date published: 2025-12-7

1-800-457-3801

SCBT Portrait Logo
Seach Input

KV1.5 Inhibitors

KV1.5 is a voltage-gated potassium channel that plays a critical role in the regulation of the electrical activity of various cell types, most notably in cardiac myocytes. This channel is responsible for the ultra-rapid delayed rectifier potassium current (I_Kur), which contributes to the repolarization phase of the cardiac action potential, thereby influencing heart rhythm and rate. The proper functioning of KV1.5 is crucial for maintaining the normal electrical stability of the heart, preventing arrhythmias, and ensuring efficient blood pumping. Beyond its role in cardiac tissue, KV1.5 is also expressed in other tissues, including the vascular smooth muscle and certain types of neurons, where it contributes to the regulation of cellular excitability and signal transduction. The modulation of KV1.5 activity can have significant effects on cellular repolarization and action potential duration, highlighting its importance in the coordination of electrical signals across various physiological systems. The inhibition of KV1.5 channels represents a mechanism by which the electrical properties of cells, especially cardiac myocytes, can be modified to address conditions associated with abnormal heart rhythms. Inhibition can occur through several mechanisms, including the direct blockage of the potassium channel pore, which prevents potassium ions from flowing out of the cell, leading to alterations in action potential repolarization. Other mechanisms might involve changes in the channel's sensitivity to voltage, modulation of its expression levels, or interference with the channel's regulatory mechanisms, such as phosphorylation state or interaction with accessory proteins. Such inhibition effectively prolongs the action potential duration and can modify cardiac excitability and contractility. The precise modulation of KV1.5 activity through its inhibition offers a targeted approach to influence the electrical activity of the heart and other excitable tissues, providing insights into the potential for regulating cellular function through the manipulation of ion channel activity.
Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

DPO-1

43077-30-1sc-203570
sc-203570A
10 mg
50 mg
$170.00
$715.00
(0)

DPO-1 is a potent KV1.5 inhibitor characterized by its ability to selectively disrupt potassium ion conduction through the channel. Its unique molecular structure facilitates specific interactions with the channel's inner vestibule, leading to a conformational change that hinders ion passage. The compound exhibits rapid kinetics, allowing for swift modulation of channel activity. Furthermore, DPO-1's hydrophobic regions enhance its membrane permeability, optimizing its interaction with lipid bilayers.

Ibutilide Fumarate

122647-32-9sc-211627
10 mg
$250.00
(0)

Ibutilide is a class III antiarrhythmic agent that activates KV1.5 channels, leading to delayed repolarization. It is used for atrial fibrillation and atrial flutter.

Apremilast

608141-41-9sc-480062
5 mg
$444.00
(0)

Apremilast is an agent in research used for certain autoimmune diseases like psoriasis and psoriatic arthritis. While its primary mechanism of action is related to immune modulation, it has been found to have some effects on KV1.5 channels.

Ibuprofen

15687-27-1sc-200534
sc-200534A
1 g
5 g
$52.00
$86.00
6
(0)

Ibuprofen, a common nonsteroidal anti-inflammatory drug (NSAID), has been shown to inhibit KV1.5 channels to some extent. This property is of interest in understanding potential off-target effects of NSAIDs.